title: Metabolic and vascular features of dynamic contrast-enhanced breast magnetic resonance imaging and (15)O-water positron emission tomography blood flow in breast cancer.
abstract: OBJECTIVE
  We sought to (1) describe associations between measures of tumor perfusion by dynamic contrast-enhanced breast magnetic resonance imaging (DCE-MRI), blood flow by (15)O-water positron emission tomography (PET) and metabolism by (18)F-fluorodeoxyglucose ((18)F)-FDG PET and (2) improve our understanding of tumor enhancement on MRI through independent measures of tumor metabolism and blood flow.
  
  
  METHODS
  We performed a retrospective analysis of the existing PET and MRI databases from the Departments of Nuclear Medicine and Radiology. We identified patients with locally advanced breast cancer who underwent (15)O-water/(18)F-FDG PET within 1 month of clinical DCE-MRI between February 2004 and August 2006. The (15)O-water PET blood flow and (18)F-FDG metabolic rate and tissue transport constant (K(1)) in the primary malignancy were calculated. DCE-MRI peak percent enhancement and peak signal enhancement ratio (SER) were measured for each tumor. Correlations and regression analysis of these variables were performed.
  
  
  RESULTS
  Fifteen patients with complete PET and DCE-MRI data were included in the analysis cohort. Peak SER correlated significantly with blood flow (r = 0.73, P = .002) and K(1) (r = 0.76, P = .001). However, peak SER did not correlate significantly with FDG metabolic rate (r = 0.44, P = .101). There were no significant correlations between peak percent enhancement and any of the PET parameters.
  
  
  CONCLUSIONS
  Our findings suggest that tumor perfusion, represented by (15)O-water PET blood flow, is an important factor in the MRI enhancement of locally advanced breast cancer. A lack of correlation of FDG metabolic rate with blood flow and DCE-MRI kinetics suggests that (18)F-FDG PET provides complementary metabolic information independent of vascular factors.
authors.affiliation: Department of Radiology, University of Washington, Seattle Cancer Care Alliance, 825 Eastlake Avenue East, G3-200, Seattle, WA 98109-1023, USA. preby@u.washington.edu
authors.forename: Peter R
authors.initials: PR
authors.lastname: Eby
authors.forename: Savannah C
authors.initials: SC
authors.lastname: Partridge
authors.forename: Steven W
authors.initials: SW
authors.lastname: White
authors.forename: Robert K
authors.initials: RK
authors.lastname: Doot
authors.forename: Lisa K
authors.initials: LK
authors.lastname: Dunnwald
authors.forename: Erin K
authors.initials: EK
authors.lastname: Schubert
authors.forename: Brenda F
authors.initials: BF
authors.lastname: Kurland
authors.forename: Constance D
authors.initials: CD
authors.lastname: Lehman
authors.forename: David A
authors.initials: DA
authors.lastname: Mankoff
mesh_terms: D001783:Blood Flow Velocity; D001943:Breast Neoplasms / Q000098:blood supply / Q000000981:diagnostic imaging* / Q000378:metabolism*; D005260:Female; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000379:methods*; D009389:Neovascularization, Pathologic / Q000000981:diagnostic imaging* / Q000378:metabolism*; D010104:Oxygen Radioisotopes / Q000493:pharmacokinetics*; D049268:Positron-Emission Tomography / Q000379:methods*; D019275:Radiopharmaceuticals / Q000493:pharmacokinetics; D014867:Water / Q000378:metabolism
chemical_list: D010104:Oxygen Radioisotopes; D019275:Radiopharmaceuticals; D014867:Water
references.citation: J Clin Oncol. 2006 Feb 10;24(5):769-77
references.pmid: 16391297
references.citation: Magn Reson Imaging Clin N Am. 1999 May;7(2):411-20, x
references.pmid: 10382170
references.citation: Magn Reson Med. 1993 May;29(5):616-22
references.pmid: 8505897
references.citation: J Cereb Blood Flow Metab. 1985 Jun;5(2):179-92
references.pmid: 3988820
references.citation: Ann Neurol. 1979 Nov;6(5):371-88
references.pmid: 117743
references.citation: J Clin Oncol. 2000 Apr;18(8):1676-88
references.pmid: 10764428
references.citation: Radiology. 1990 Sep;176(3):791-9
references.pmid: 2389038
references.citation: Circ Res. 1979 Jan;44(1):127-37
references.pmid: 363301
references.citation: Acta Radiol. 2003 Jul;44(4):373-8
references.pmid: 12846686
references.citation: Cancer Invest. 1998;16(4):225-30
references.pmid: 9589031
references.citation: J Comput Assist Tomogr. 2002 Jul-Aug;26(4):510-4
references.pmid: 12218810
references.citation: Breast Cancer Res Treat. 2005 May;91(1):1-10
references.pmid: 15868426
references.citation: Magn Reson Imaging Clin N Am. 1994 Nov;2(4):633-58
references.pmid: 7489314
references.citation: AJR Am J Roentgenol. 2000 Oct;175(4):1029-33
references.pmid: 11000158
references.citation: Radiology. 2007 Sep;244(3):727-35
references.pmid: 17709827
references.citation: Lancet Oncol. 2003 Dec;4(12):759
references.pmid: 14662432
references.citation: Lancet. 1984 Jan 21;1(8369):131-4
references.pmid: 6140443
references.citation: J Nucl Med. 2002 Apr;43(4):500-9
references.pmid: 11937594
references.citation: J Magn Reson Imaging. 1999 Sep;10(3):260-6
references.pmid: 10508285
references.citation: J Nucl Med. 2004 Nov;45(11):1829-37
references.pmid: 15534051
references.citation: Clin Cancer Res. 2006 Oct 1;12(19):5659-67
references.pmid: 17020967
references.citation: J Neurochem. 1977 May;28(5):897-916
references.pmid: 864466
references.citation: J Nucl Med. 2003 Nov;44(11):1806-14
references.pmid: 14602864
references.citation: J Clin Oncol. 1993 Nov;11(11):2101-11
references.pmid: 8229124
references.citation: Eur Radiol. 2001;11(10):2058-70
references.pmid: 11702142
references.citation: Ann Oncol. 2006 Sep;17(9):1393-8
references.pmid: 16788001
references.citation: J Magn Reson Imaging. 2007 Sep;26(3):615-23
references.pmid: 17729334
references.citation: Radiology. 1990 Dec;177(3):633-41
references.pmid: 2243962
references.citation: J Clin Oncol. 1995 Jun;13(6):1470-7
references.pmid: 7751894
references.citation: Radiology. 1999 Apr;211(1):101-10
references.pmid: 10189459
references.citation: NMR Biomed. 2002 Apr;15(2):154-63
references.pmid: 11870911
references.citation: Breast J. 1999 Jan;5(1):13-21
references.pmid: 11348250
references.citation: Cancer Res. 1992 Mar 15;52(6):1592-7
references.pmid: 1540969
references.citation: Radiology. 2006 May;239(2):361-74
references.pmid: 16543585
references.citation: Magn Reson Med. 2004 Aug;52(2):420-9
references.pmid: 15282828
references.citation: Cancer. 2008 Jan 1;112(1):17-26
references.pmid: 18000804
references.citation: Magn Reson Med. 2000 Sep;44(3):450-6
references.pmid: 10975898
references.citation: J Clin Oncol. 2000 Apr;18(8):1689-95
references.pmid: 10764429
references.citation: Eur Radiol. 2003 Jan;13(1):80-7
references.pmid: 12541113
references.citation: Magn Reson Imaging. 2007 Apr;25(3):319-27
references.pmid: 17371720
references.citation: Radiology. 2004 Dec;233(3):830-49
references.pmid: 15486214
references.citation: Acad Radiol. 2004 Oct;11(10):1115-24
references.pmid: 15530804
references.citation: Eur Radiol. 2003 Jul;13(7):1635-44
references.pmid: 12835979
references.citation: Microcirculation. 2004 Jul-Aug;11(5):387-96
references.pmid: 15280064
references.citation: Stud Health Technol Inform. 1999;62:259-60
references.pmid: 10538368
references.citation: Eur J Nucl Med Mol Imaging. 2003 Feb;30(2):274-80
references.pmid: 12552346
references.citation: Breast Cancer Res Treat. 2004 Jan;83(1):67-76
references.pmid: 14997056
references.citation: AJR Am J Roentgenol. 2005 Jun;184(6):1774-81
references.pmid: 15908529
references.citation: Magn Reson Med. 2007 Sep;58(3):572-81
references.pmid: 17685424